Skip to main content

Table 3 Patient outcomes at baseline and the end of 3 months

From: Correlation of glycemic regulation and endotrophin in patients with type 2 Diabetes; pilot study

  Normal ranges Baseline
n = 42
Third Month
n = 42
p value
Endotrophin 15.35 ± 9.77 12.20 ± 6.49 0.010
HbA1c (%) ≤ 7 10.90 ± 1.71 6.64 ± 0.36 < 0.001
Fasting glucose (mg/dL) < 104 258.97 ± 93.55 125.97 ± 14.63 < 0.001
CRP (mg/L) 0–5 6.01 ± 4.24 4.60 ± 3.69 0.050
BMI (kg/m2) 18–25 29.37 ± 4.64 29.29 ± 4.41 0.412
HDL, mg/dL > 50 43.92 ± 8.96 44.14 ± 8.38 0.865
LDL, mg/dL < 130 144.14 ± 32.64 136 ± 69 ± 30.82 0.160
TG, mg/dL < 150 197.97 ± 100.22 180.66 ± 78.71 0.208
UACR, mg/g 0–30 15.35 ± 16.04 10.80 ± 9.75 < 0.001
  1. BMI body mass index, HbA1c hemoglobin A1c, CRP, C-reactive protein, HDL high-density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol, TG triglyceride, UACR urinary albumin to creatinine(mg/g) ratio